Employees Retirement System Of Texas Bei Gene, Ltd. Transaction History

Employees Retirement System Of Texas

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$115.78 - $208.34 $694,680 - $1.25 Million	-6,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$107.01 - $175.15 $642,060 - $1.05 Million	6,000 New	6,000 $842,000
Q2 2018 Aug 10, 2018	SELL	$152.5 - $216.77 $3.2 Million - $4.55 Million	-21,000 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$97.41 - $177.22 $1.85 Million - $3.37 Million	-19,000 Reduced 47.5%	21,000 $3.53 Million
Q4 2017 Feb 09, 2018	BUY	$79.6 - $114.73 $3.18 Million - $4.59 Million	40,000 New	40,000 $3.91 Million

Q3 2017 Nov 13, 2017	SELL	$66.19 - $103.46 $4.2 Million - $6.56 Million	-63,450 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	63,450	63,450 $2.86 Million

216

45.1M

76.5K

72.3K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $15.2B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.